Antibodies is an international, peer-reviewed, open access journal on immunoglobulins, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, ESCI (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and many other databases.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 18.3 days after submission; acceptance to publication is undertaken in 6.9 days (median values for papers published in this journal in the first half of 2021).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Add your e-mail address to receive forthcoming issues of this journal:
Special Issue in Antibodies
Development and Application of Antibody Against Small Molecule Phytoproduct Guest Editors: Yukihiro Shoyama, Hiroyuki Tanaka, Seiichi Sakamoto
Deadline: 31 July 2021
Special Issue in Antibodies
New, Old, and Shared Antibody Specificities in Autoimmune Diseases Guest Editor: Loredana Frasca
Deadline: 20 August 2021
Special Issue in Antibodies
Antibody Engineering for Cancer Immunotherapy Guest Editors: Silvia Crescioli, Sophia Karagiannis, Ann White
Deadline: 31 August 2021
Special Issue in Antibodies
Antibody-Based Therapeutics Against COVID-19 Guest Editor: Rui Gong
Deadline: 20 September 2021
Topical Collection in Antibodies
Computational Antibody and Antigen Design Collection Editor: Buyong Ma
Back to TopTop